MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$35,514,032
Net loss
-$34,257,370
Accrual of paid-in-kind
dividends on series a...
-$1,256,662
Loss before income
taxes
-$34,036,274
Deferred income tax
(expense) benefit
$221,096
Loss from operations
-$27,968,445
Total other expense
-$6,067,829
Interest income
(expense), net
$96,938
Total operating
expenses
$27,968,445
Loss on debt
conversion with related...
-$6,134,120
Exchange loss, net
-$27,916
Loss on fixed asset
disposal
-$2,731
Research and development
$21,866,071
General and
administrative expenses
$6,102,374
Back
Back
Income Statement
source: myfinsight.com
Dogwood Therapeutics, Inc. (DWTX)
Dogwood Therapeutics, Inc. (DWTX)